DIALYSIS · CCN 672739

DaVita Crosstimbers Dialysis

HOUSTON, TX 77022

DialysisProfitDaVita
$5.1M
TOTAL REVENUE
26.4%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.1M
Total costs
$3.8M
Operating income (rev − costs)
$1.4M
Operating margin
26.4%
Total charges
$4.7M
Total treatments
12,712
Dialysis stations
12

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.6218—
Fistula Rate
DFC_FISTULA_RATE
62.678—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.3730—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
1——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
146.188—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.21——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1878—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
30.1353—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
22.980—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
27.558—
Standardized ED Visits Ratio
DFC_SEDR
1.0822—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
53.122—